Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANGIOTENSIN II
- Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
- Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass
- Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
- SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
- Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
- A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
- Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
- Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
- Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
- Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
- Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy
- Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
- Therapy to Maintain Remission in Dilated Cardiomyopathy
- Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites
- The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
- Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)
- Initiation of ARNi and SGLT2i in Patients With HFrEF
- Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
- Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
- Pre-operative Antihypertension Strategies-Carotid Artery Stenting
- Ethosomal Gel Bearing Losartan 5% for Keloid Treatment
- Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
- Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients
- GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer
- A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
- Effect of Dapagliflozin on Secondary Mitral Regurgitation
- Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension
- Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
- Losartan and Memory
- Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
- Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
- Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
- Patiromer Trial in CKD Stage IIIB to V
- Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease
- Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
- Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal Anesthesia
- Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients
- The Fontan Dapagliflozin Pilot Study
- Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
- rhBNP in Type 3 Pulmonary Hypertension
- A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
- Empagliflozin in ESKD - A Feasibility Study
- Colchicine and Inflammation in Hemodialysis Patients
- Angiotensin Receptor-Neprilysin Inhibitor After Transcatheter Aortic Valve Implantation
- Chymase Angiotensin-(1-12) Axis In Hypertensive Disease
- Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease
- ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
- Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis
- International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response
- Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
- " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
- Sex Differences in the Dilatory Response of Compound 21
- Safety of Ibuprofen After Major Orthopaedic Surgeries
- LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
- Enoxolone in Major Depression - Biomarker-outcome Relationship
- Superselective Adrenal Arterial Embolization for Resistant Hypertension
- Evaluation of the Efficacy of Mouth Rinses With Commercial Mouthwashes to Decrease Viral Load in Saliva in COVID-19 Patients
- Precision Treatment With Angiotensin Converting Enzyme Inhibitor
- A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
- The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction
- Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients
- Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
- Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
- Comparing the Hemodynamic Effects of Volume Loading vs Non-loading During Induction of Anesthesia in Fluid Responder Patients With Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Graft Surgery: a Randomized Controlled Study.
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney
- Mineralocorticoid Use in COVID-19 Patients
- Study to Verify the Effectiveness and Safety of the Modified Isothymol or Carvacrol Compound Against SARS-CoV-2
- ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)
- Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
- Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
- Effect of Dapagliflozin in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF)
- Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction
- Effects of Triiodothyronine (T3) in Ischemic Heart Failure
- Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
- Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
- Effect of Different Antihypertensive Drugs on Central Blood Pressure
- DAPAgliflozin for Renal Protection in Heart Transplant Recipients
- Angiotensin-(1-7) Cardiovascular Effects in Aging
- To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
- Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy
- Enhancing the Natriuretic Peptide System in HFpEF
- STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
- Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.
- Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
- Exercise-induced Erythropoiesis: the Mechnistic of Angiotensin II
- TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension
- Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis
- Intra-lesional ACE Inhibitor for Treatment of Keloid Scars
- Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
- Micophenolate Mofetil Versus Azathioprine in Myocarditis
- Reducing Acute Kidney Injury Occurence by Administering Angiotensin II
- Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Childr
- Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock
- Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
- Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19
- A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients
- Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
- Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
- Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)
- Evaluation of IGM-6268 in Healthy Volunteers
- Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty
- Occurrence of Dyskalemia With Treatment for Hypertension
- Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B
- Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
- Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
- Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial
- Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
- The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF
- Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
- Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.
- The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19
- Multidiscipline Care for Acute Kidney Disease (AKD)
- Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices
- Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
- The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
- Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
- Empagliflozin in Diuretic Refractory Ascites
- Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
- The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart Failure
- Lokelma for RAAS Maximisation in CKD & Heart Failure.
- Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.
- The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling
- The ORTIZ Study: Optimising RASi Therapy With SZC
- Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy
- Cardioprotection in AML
- Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood Pressure
- Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients
- Effect of Losartan or Eprosartan on Fructose Hyperuricemia
- Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
- Novel Experimental COVID-19 Therapies Affecting Host Response
- Angiotensin Receptor Blockers in Aortic Stenosis
- Angiotensin II for Distributive Shock
- Angiotensin II in Liver Transplantation
- An Open-Label Study of Apabetalone in Covid Infection
- The GUARDIAN Trial
- The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
- SER150 vs Placebo in Diabetic Kidney Disease
- Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.
- Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
- Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19
- Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH
- Urine Alkalinisation in COVID-19
- Dapagliflozin in Non-diabetic Stage IV CKD
- Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine
- COVID-19 Antithrombotic Rivaroxaban Evaluation
- Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device
- Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions
- Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.
- Investigation the Effect of Montelukast in COVID-19
- INvestigating TELmisartin Study
- Secondhand Tobacco Smoke and Cardiovascular Disease
- Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients
- Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus
- GOREISAN for Heart Failure (GOREISAN-HF) Trial
- Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
- Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
- Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
- A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
- Sacubitril/Valsartan in Resistant Hypertension
- Use of Angiotensin-(1-7) in COVID-19
- Polypill Strategy for Heart Failure With Reduced Ejection Fraction
- Losartan for Improved Vascular Endothelial Function After Preeclampsia
- Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC
- Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
- Losartan Effects on Emotion-memory Interaction
- Angiotensin 1-7 as a Therapy in the Treatment of COVID-19
- The Effects of Losartan on Reward Reinforcement Learning
- Angiotensin 2 for AKI After OLT
- The COVID-RASi Trial (COVID-19)
- Influence of Sacubitril/Valsartan on Autonomic Cardiac Nervous System in Heart Failure Patients: an Exploratory Study
- Comparison of Potassium Binders in the ER
- Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects
- Ramipril in Pediatric Patients on Hemodialysis
- Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)
- Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19
- Atrasentan in Patients With IgA Nephropathy
- Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure
- Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients
- Ravulizumab and COVID-19
- Renin and Renal Biomarker Response to Angiotensin II
- The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes
- Estrogen Therapy in Non-severe COVID-19 Patients
- COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7
- Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19
- Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
- Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients
- Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
- FREEDOM COVID-19 Anticoagulation Strategy
- Telmisartan in Respiratory Failure Due to COVID-19
- Management of Angiotensin Inhibitors During the Perioperative Period
- Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS
- Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19
- Cyclosporine For The Treatment Of COVID-19(+)
- The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19
- Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
- Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
- Randomized Placebo-controlled Analysis of Superior Laryngeal Nerve Block for Neurogenic Cough
- Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
- A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN
- Candesartan as an Adjunctive Treatment for Bipolar Depression
- Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
- Multitarget Therapy for Idiopathic Membranous Nephropathy
- Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
- Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease
- TXA127 for the Treatment of Severe COVID-19
- Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration
- Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
- Silymarin in COVID-19 Pneumonia
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
- Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus
- Oral 25-hydroxyvitamin D3 and COVID-19
- Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure
- Atorvastatin as Adjunctive Therapy in COVID-19
- Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2
- Leptin Infusion and Endothelial Vasomotor Response
- The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
- African American Study of Kidney Disease and Hypertension
- Isotretinoin in Treatment of COVID-19
- Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
- Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19
- Telmisartan for Treatment of COVID-19 Patients
- Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)
- Stopping ACE-inhibitors in COVID-19
- Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
- Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response
- Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.
- Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19
- COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)
- Early Treatment of ARNI on Myocardial Remodeling and Progress
- Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
- Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
- Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects
- Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
- Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19
- Coronavirus (COVID-19) ACEi/ARB Investigation
- Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19
- Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
- The Impact of Camostat Mesilate on COVID-19 Infection
- Norepinephrine Infusion During Cardiopulmonary Bypass
- NO Prevention of COVID-19 for Healthcare Providers
- Effect of Atorvastatin on Carotid Intima Media Thickness
- Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
- Asian Diabetes Outcomes Prevention Trial
- The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney
- Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.
- REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations
- Renohemodynamic Effects of Combined empagliflOzin and LosARtan
- NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure
- Ertugliflozin for Functional Mitral Regurgitation
- Captopril Versus Atenolol to Prevent Expansion Rate of Thoracic Aortic Aneurysms
- Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients
- The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
- How Atorvastatin Affects the Gut Flora and Metabolomics?
- Losartan to Improve Hip Microfracture
- Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD
- Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
- Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
- Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC
- Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
- Explorative Study for Treating Persistent Developmental Stuttering With Ramipril
- A Phase 2b Diabetic Kidney Disease Study
- Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
- One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
- Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis
- SGLT2 Inhibitors in Glomerular Hyperfiltration
- Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
- Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction
- Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
- Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
- Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
- Non Invasive Assessment of Heart Failure
- The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia
- Angiotensin 2 for Hepatorenal Syndrome
- Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children
- Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
- Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
- Improving 24-hour Blood Pressure in Obstructive Sleep Apnea
- Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
- A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy
- Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury
- The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
- Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension
- Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
- Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
- Impact of Angiotensin Converting Enzyme Activity on Exercise Training Sensitivity
- Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
- The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
- Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.
- Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors
- Preventing Acute Kidney Injury (AKI) in Neonates
- The Role of Sacubitril/Valsartan in Post-acute Myocardial Infarction
- Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
- Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
- A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
- The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients
- Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
- Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure
- Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy
- Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD
- Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery
- Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
- Bisoprolol in DMD Early Cardiomyopathy
- Angiotensin-(1-7) and Energy Expenditure in Human Obesity
- Effect of Some Drugs on Liver Fibrosis
- Statins and ARBs on Rheumatoid Activity
- Losartan and Emotional Memory
- A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
- Prevention of Cardiac Dysfunction During Breast Cancer Therapy
- Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome
- PDD in Type 2 Diabetes w/wo Diastolic Dysfunction
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
- Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine
- Angiotensin II in General Anesthesia
- Lidocaine to Prevent Cough and Hemodynamic Changes in Tracheal Extubation
- Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis
- Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery.
- Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
- MR Antagonist and STRIATIN
- ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)
- Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.
- Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
- Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
- Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
- Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension
- Pentoxifylline in Diabetic Kidney Disease
- Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy
- Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
- Angiotensin 1-7 in Obesity Hypertension
- Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On
- Vitamin B Complex and Diabetic Nephropathy in Type 1 Diabetes
- Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
- A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure)
- Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
- Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
- The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
- Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.
- Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
- Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis
- Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
- Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia
- Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients
- H-Type Hypertension Precision Medicine Trial
- Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
- Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension
- The Effect of Losartan on Emotional Processing in Healthy Volunteers
- Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women
- A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation
- S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
- Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure
- Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction
- Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes
- Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.
- Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
- Vascular Dysfunction in Hypertensive Postmenopausal Women
- The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
- Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
- Spironolactone Therapy in Chronic Stable Right HF Trial
- AT1R Blockade and Periodic Breathing During Sleep in Hypoxia
- Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
- Angiotensin II for Septic Shock Treatment
- ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
- Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension
- Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD
- A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension
- PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?
- Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
- Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG
- Angiotensin-(1-7) in Peripheral Arterial Disease
- A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
- An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes
- Ixazomib for Desensitization
- Study of Renin-angiotensin System in Mechanically Ventilated Subjects
- Spironolactone on Acute Kidney Injury in Critically Ill Patients
- Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
- Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)
- Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis
- Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin
- Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
- Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria
- The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure
- Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
- The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)
- A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)
- Open-label Study on Treatment of Primary Aldosteronism With Everolimus
- Empaglifozin in Early Diabetic Kidney Disease
- A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
- Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction
- This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
- This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)
- Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease
- Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
- Matão Controlling Hypertension (MatCH Study): Rationale and Design
- Pilot of Zinc Acetate to Improve Chronic Cough
- A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
- Empagliflozin in Post-Transplantation Diabetes Mellitus
- EMPRA (EMPagliflozin and RAs in Kidney Disease)
- Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study
- Race, Natriuretic Peptides and Physiological Perturbations
- First in Human Single Ascending Dose Study of MOR107
- A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
- Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients
- Genetic Determinants of ACEI Prodrug Activation
- Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus
- Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome
- Anakinra Versus Placebo for the Treatment of Acute MyocarditIS
- Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease
- Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
- Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
- Impact of the Administration of Fludrocortisone in Very Premature Infants
- Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
- Corticosteroid Rhythms in Hypoparathyroid Patients
- Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
- : Vascular Function in Health and Disease
- Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes
- Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?
- Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
- Mgt of Chronic Subdural Hematoma Using Dexamethasone
- The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
- A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
- Cardiovascular Effects of Empagliflozine
- Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
- Riociguat in Scleroderma Associated Digital Ulcers
- Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
- Comprehensive Treatment of Angina in Women With Microvascular Dysfunction
- Effect of 80-mg Atorvastatin on Myocardial Edema
- Sodium Thiosulfate to Preserve Cardiac Function in STEMI
- Expression and Function of the Renin-Angiotensin System in the Esophagus
- Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
- Effect of Statin Use on Aldosterone Secretion
- The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production
- Comparison of Taste and Palatability in Fiber Supplements
- Ramipril Treatment of Claudication
- Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
- Postoperative Hemodynamics Comparison After High Spinal Block With or Without Intrathecal Morphine.
- NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
- CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
- EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
- Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
- Intensive Versus Conventional Digoxin Use in Patients With Heart Failure
- Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
- Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
- Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure
- The Precision Hypertension Care Study
- Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?
- Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
- Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation
- CleanUP IPF for the Pulmonary Trials Cooperative
- The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites
- Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
- N-of-1 Trials for Blood Pressure Medications in Adults
- Perindopril vs Ramipril for Persistence in MAU Reduction Study
- SGLT2 Inhibition and Left Ventricular Mass
- Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
- Remission Clinic in Proteinuric Chronic Nephropathies
- The Role of Endothelin-1 in Sickle Cell Disease
- A Controlled Trial of Losartan in Posttraumatic Stress Disorder
- Losartan Effects on Emphysema Progression
- Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
- Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients
- Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation
- Canrenone as Add-on in Patients With Essential Hypertension
- Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects
- Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
- Renoprotective Effects of Dapagliflozin in Type 2 Diabetes
- ACE-inhibitors in Extracapillary Glomerulonephritis
- Effect of Melatonin on Cardiometabolic Risk- FULL
- Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
- The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study
- Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate
- Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease
- Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
- Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
- Metabolic Effects of Angiotensin-(1-7)
- Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
- Dobutamaine Versus Milrinone in Cardiorenal Syndrome
- Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study
- Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.
- Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs
- The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
- Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
- ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)
- Nesiritide in Hypertension
- Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients
- Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
- Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
- Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
- Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
- COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF
- Physiologic Interactions Between the Adrenal- and the Parathyroid Glands
- Renal Function During Pediatric Anesthesia
- The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
- Comparative Evaluation of the Effect on Blood Pressure of an Equivalent Content of Sodium in the Form of Bicarbonate of Sodium and in the Form of Sodium Chloride, on "Sensitive Sodium" Subjects
- Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
- The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
- Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients
- A Crossover Pilot Study of the Effect of Amiloride on Proteinuria
- The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease
- Postoperative Pain and Angiotensin II Receptor Antagonists
- Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
- Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
- Health Evaluation in African Americans Using RAS Therapy
- RAS Peptide Profiles in Patients With Arterial Hypertension
- Colchicine for Diabetic Nephropathy Trial
- Evaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop Hypertension
- Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial
- High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
- Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery
- Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
- Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
- Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
- Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)
- Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans
- Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
- Acthar on Proteinuria in IgA Nephropathy Patients
- Blood Pressure Regulation - Role of Potassium
- Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
- Lowering Blood Pressure in Primary Care in Vienna
- INTERVENCION Trial
- Optimum Treatment for Drug-Resistant Hypertension
- Drug to Prevent Pneumonia in the Tube Fed
- A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
- The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)
- Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
- The Effect of Uric Acid Lowering in Type 1 Diabetes
- A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
- Evaluate the Efficacy of Fenofibrate on Microalbuminuria
- Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients
- Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study
- Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
- Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction
- Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms
- Response of VEGF and AT-II to HCG in PCOS
- Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)
- Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population
- Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
- Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients
- Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients
- Treatment of Hypertension in Tibetan Adult Population
- The Use of Angiotensin Receptor Blockers and the Risk of Cancer
- Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
- Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
- Residual Renal Function Preservation in Peritoneal Dialysis Patients
- Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
- Effects of Onion Peel Extract on Endothelial Function
- Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)
- Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
- Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
- Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
- XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
- Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "
- Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
- Paricalcitol in Fabry Disease
- Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
- Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
- Intermittent Hypoxia 2: Cardiovascular and Metabolism
- Comparative Study of the Effects of Telmisartan and Nebivolol
- Spironolactone Against Anthracycline-induced Cardiomyopathy
- Use of Sitagliptin to Decrease Microalbuminuria
- Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
- Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
- Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria
- Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism
- Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
- Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
- Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System
- Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
- Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
- Non-invasive Haemodynamic Assessment in Hypertension
- Angiotensin II Antagonist in Severe Sepsis
- Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study
- A Study of Muscle Strength Maintenance in Older Adults
- Vascular Dysfunction in Human Obesity Hypertension
- Cardiomyopathy in DMD: Lisinopril vs. Losartan
- Sevelamer in Proteinuric CKD
- Comparision of Blood Pressure Variability Between Amlodipine and Losartan
- Pilot Study of Perindopril in Childhood Cancer Survivors
- Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart
- The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
- A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
- Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
- Protocolized Diuretic Strategy in Cardiorenal Failure
- Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema
- Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
- Study of Losartan in the Treatment of NAFLD in Children
- Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers
- A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
- Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)
- Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects
- Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo
- Aldosterone Antagonism and Microvascular Function
- HALT Progression of Polycystic Kidney Disease Study B
- Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
- Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
- ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
- Study Of Diabetic Nephropathy With Atrasentan
- Losartan in Decompensated Heart Failure
- Ramipril for the Treatment of Oligospermia
- Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
- The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
- Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
- HIGH Altitude CArdiovascular REsearch in the ANDES
- RAS Quantification in Patients With Aliskiren or Candesartan
- Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
- Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD
- Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
- Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects
- Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma
- Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression
- MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
- RAS-Peptide-Profile Study in Healthy Male Subjects
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
- Mitigation of Radiation Pneumonitis and Fibrosis
- Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
- Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease
- Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
- Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose
- The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
- Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
- Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
- Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
- Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS
- Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
- FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
- The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
- A Trial of Fimasartan for Early Diastolic Heart Failure
- Angiotensin II Blockade and Inflammation in Obesity
- Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)
- The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension
- CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function
- Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?
- Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
- Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
- Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
- Beta Blocker Therapy in Moderate to Severe COPD
- Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers
- Resistant Hypertension Optimal Treatment
- Study of Cardiovascular Disease and Obstructive Sleep Apnea
- The VALIDATE-D Study
- GRK4 Polymorphisms Blood Pressure Response to Candesartan
- Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
- Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
- New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
- Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine
- The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
- A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)
- Renal Effects of Erythropoietin in Humans
- Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
- Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema
- Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery
- A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy
- Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
- Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
- Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition
- The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria
- IL1-TRAP, Rilonacept, in Systemic Sclerosis
- Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients
- ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
- Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy
- Nesiritide in Resistant Hypertension
- Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
- Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
- Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria
- The Effect of Vitamin D Supplementation on Arterial Stiffness in Diabetic Patients
- Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
- Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment
- A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus
- Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension
- Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
- Shiga Microalbuminuria Reduction Trial-2
- Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy
- Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker
- Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients
- Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF
- Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
- The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
- Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
- Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy
- Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension
- Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
- A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
- Pharmacogenetics of Ace Inhibitor-Associated Angioedema
- Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis
- The Effect and Safety of Lisinopril in Non-hypertensive Men With Infertility From Low Sperm Count
- Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan
- Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
- An Open-labeled Trial of Ramipril in Patients With Migraine
- A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril
- Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes
- Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
- Steroids and Azathioprine in Advanced IgAN
- The Effect of Losartan in Bicuspid Aortic Valve Patients
- Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
- Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
- Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
- Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris
- The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension
- Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled D
- Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
- The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
- Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
- Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet
- Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects
- Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
- Effects of Saxagliptin on Endothelial Function
- Aliskiren on Retinal Vasculature Treatment Study
- Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
- Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
- The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
- Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
- Vitamin D Supplementation in Chronic Stable Heart Failure
- Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
- Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
- Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
- Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
- PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer
- CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression
- Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
- Atorvastatin and Sympathetic Activity in Chronic Kidney Disease
- Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
- Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure
- Effect of Bosentan in Scleroderma Renal Crisis
- Combined Antihypertensive Therapy and Sexual Dysfunction
- Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
- Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
- Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
- Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial
- Telmisartan Versus Losartan in Kidney Transplantation
- Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
- Influence of Aliskiren on Proteinuria
- The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man
- Local Vasoconstriction in Postural Tachycardia Syndrome
- Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)
- Recurrent Stroke Prevention Clinical Outcome Study
- n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
- Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
- A Study of Aleglitazar in Combination With Ibuprofen in Healthy Volunteers
- A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers
- Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
- Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy
- Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome
- Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
- Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
- AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study
- Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
- Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease
- Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease
- Treatment of Adiposity Related hypErTension (TARGET)
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
- Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)
- The Confirmatory Olmesartan Plaque Regression Study
- Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
- Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
- Effects of Spironolactone in Dialysis
- Niacin/Laropiprant and Endothelial Function
- Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes
- AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)
- Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System
- Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
- A Study in Participants With Diabetic Kidney Disease
- Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
- Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine
- Prevention of Left Ventricular Dysfunction During Chemotherapy
- Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
- Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
- Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
- Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children
- Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia
- Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
- Aliskiren in Patients With Idiopathic Membranous Nephropathy
- Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure
- Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study
- Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
- Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
- An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)
- Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet
- Survey to Assess Why People Are Not Responding to Treatment in Hypertension
- The Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary Angiography
- The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis
- An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
- Aldosterone Blockade Early After Acute Myocardial Infarction
- Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Evaluation of Effects of Exercise Training and ARB in DM Patients
- Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
- Impact of Diabetes on Left Ventricular Remodeling
- Anti-Fibrotic Effects of Losartan In Nash Evaluation Study
- Interaction of Apelin and Angiotensin in the Systemic Circulation
- The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
- Add-on Aliskiren Treatment in Patients With Chronic Congestive Heart Failure
- Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants
- Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
- Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
- Amlodipine Prevents Morning Blood Pressure Surge Study
- Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)
- Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
- Role of Angiotensin II in Insulin-induced Microvascular Activity
- Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
- Effect of Turmeric on Diabetic Nephropathy
- Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)
- Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
- Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients
- Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes
- Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study
- Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients
- Preoperative Ephedrine Attenuates the Hemodynamic Responses of Propofol During Valve Surgery: A Dose Dependent Study
- Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
- Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics
- Effect of Candesartan in Alcoholic Liver Fibrosis
- Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis
- The Effects of Decreasing the Lasix Dose on the Cardiorenal System
- Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
- Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's
- The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
- Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
- Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
- The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
- Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
- B-type Natriuretic Peptide (BNP) in Human Hypertension
- Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy
- Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients
- Evaluation of New Markers to Assess Kidney Function
- Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
- Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C
- The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome
- Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure
- Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade
- Metformin in Overweight Type 2 Diabetes Mellitus
- The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
- Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity
- Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors
- Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy
- Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria
- Interaction of Apelin and Angiotensin in the Human Forearm Circulation
- Interaction of Apelin and Angiotensin in the Human Forearm Circulation
- Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation
- Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
- Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
- Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
- Aliskiren for Immunoglobulin A (IgA) Nephropathy
- Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
- Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis
- Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
- Mycophenolate Mofetil for IgA Nephropathy
- Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
- Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
- Olmesartan on Ambulatory Blood Pressure Change
- Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children
- Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
- Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes
- Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
- A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria
- Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
- Renin Profiling in Selection of Initial Antihypertensive Drug
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
- Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
- Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
- Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment
- Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure
- Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)
- Morning Hypertension and Preminent Therapy Study
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
- Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan
- Anakinra to Prevent Post-infarction Remodeling
- Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
- Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.
- Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
- Adiponectin and Insulin Resistance in Diabetic Nephropathy
- Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
- Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus
- Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension
- Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
- The Role of Mineralocorticoid Receptors in Vascular Function
- If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure
- Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy
- Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i
- Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN)
- Regression of Fatty Heart by Valsartan Therapy
- Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
- Rapid Versus Prolonged Inpatient Up-Titration of Captopril
- The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution
- Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy
- Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
- Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes
- Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?
- Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
- Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
- The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness
- Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
- Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
- Aliskiren and Muscle Sympathetic Nerve Activity
- Angiotensin in Septic Kidney Injury Trial
- Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment
- The Potential of Candesartan to Retard the Progression of Aortic Stenosis
- An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.
- A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
- Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes
- Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
- A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients
- Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3
- Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
- Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease
- The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
- The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
- Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis
- Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus
- The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy
- Effects of Losartan on Insulin Resistance in Patients With Heart Failure
- Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
- Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
- Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS
- A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
- The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome
- Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension
- Bosentan Use in Patients With Diabetic Nephropathy
- Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
- Blood Pressure Lowering in Acute Stroke Trial (BLAST)
- Combined Renin Inhibition/Beta-blockade
- Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
- Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
- Antihypertensive Response to Losartan and Genetic Polymorphisms
- The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
- Irbesartan and Adhesion Molecules in AF
- The RAS, Fibrinolysis and Cardiopulmonary Bypass
- The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)
- The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
- Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan
- Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes
- Losartan Versus Atenolol for the Treatment of Marfan Syndrome
- Effect of Gene Variants on Dopamine Receptor Natriuretic Responses
- Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
- Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
- Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
- Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension
- Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent
- Moexipril for Primary Biliary Cirrhosis
- Angiotensin-II Blockade in Mitral Regurgitation
- Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
- African American Study of Kidney Disease and Hypertension ABPM Pilot Study
- Hypertension in Hemodialysis Patients (Aim 3)
- Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
- Optimalization of Nephroprotection Using N-Acetylcysteine
- Optimalization of Nephroprotection Using Atorvastatin (Sortis)
- Polypill For Prevention of Cardiovascular Disease
- Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
- PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites
- Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
- Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels
- Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus
- VA NEPHRON-D: Diabetes iN Nephropathy Study
- Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
- Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
- CCB Safety Study in Treatment of Hypertension of ADPKD
- A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
- Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients
- Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
- Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
- Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure
- Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
- A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension
- Effect of Enalapril Plus Folic Acid on Blood Pressure and Glycometabolism
- Losartan Therapy in Pulmonary Hypertension
- Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
- Diurnal Variation of Plasminogen Activator Inhibitor-1
- Preventing Microalbuminuria in Type 2 Diabetes
- Rosiglitazone on Microalbuminuria in Type 2 Diabetics
- Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
- Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
- Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
- The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
- Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
- Kanagawa Combination Anti-hypertensive Therapy (K-CAT)
- Sympathetic Nervous System Modulation in Hypertension
- Telmisartan in Haemodialysis Patients With Chronic Heart Failure
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients
- Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
- Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study
- Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
- Chicken-Diet vs. Enalapril to Reduce Albuminuria
- Safety and Pharmacodynamic Study of CD-NP
- The Effects of Milk Proteins on Blood Pressure
- The Effct of Chitooligosaccharide on Immune Function in Healthy Adults
- A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery
- Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
- Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
- Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
- Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
- Vitamin D and Blood Pressure
- The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
- Nijmegen Antihypertensive Management Improvement Study
- Prevention of Diabetes and Hypertension
- Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
- Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
- The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
- Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
- The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
- The Efficacy of Spironolactone in Patients With Resistant Hypertension
- Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network
- Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction
- Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
- The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
- Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan
- Study of Renal Blood Flow During Human Endotoxemia
- Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
- Telmisartan and Losartan in Hypertensive IGT
- Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
- Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
- Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy
- Treating the Endothelium to Restore Insulin Sensitivity
- A Pharmacogenomic Study of Candesartan in Heart Failure
- Effects of Peptides Derived From Fermented Milk on Blood Pressure Regulation System in Healthy Volunteers.
- Acetylcarnitine and Insulin Sensitivity
- Irbesartan and Atenolol in Hypertensive Heart Disease
- Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
- Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
- Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study
- A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
- Improving Outcomes in Patients With Kidney Disease Due to Diabetes
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension
- GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
- Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
- Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
- Pioglitazone and Losartan Provides Additional Renoprotection
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
- Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
- Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure
- Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
- Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome
- Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure
- Renoprotection in Early Diabetic Nephropathy in Pima Indians
- Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
- A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
- Ramipril - Hypertension
- Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
- Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
- Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity
- Angiotensin II Antagonism of TGF-Beta 1
- Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
- Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
- Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects
- Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
- Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
- Eplerenone, ACE Inhibition and Albuminuria
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
- Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker
- Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
- Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
- Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C
- Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
- Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
- Primary Prevention of Hypertension in Obese Adolescents
- Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
- AVE7688 in Patients With Mild to Moderate Blood Pressure
- HALT Progression of Polycystic Kidney Disease Study A
- Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
- NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels
- The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant
- Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
- DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
- SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients
- Ramipril in Rheumatoid Arthritis
- The Use of Cilostazol in Patients With Diabetic Nephropathy
- A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.
- The Use of ACE Inhibitors in the Early Renal Post-transplant Period
- Management With Accupril Post Bypass Graft
- Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
- The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study
- Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis
- BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
- A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
- A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.
- Reducing Total Cardiovascular Risk in an Urban Community
- Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
- Prevention of Decompensation in Liver Cirrhosis
- Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)
- Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
- Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
- PHARES Study: Management of Resistant Hypertension
- Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
- Treatment of Orthostatic Hypotension in Autonomic Failure
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
- Aldosterone and Vascular Disease in Diabetes Mellitus
- High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
- Effects of Tetrahydrobiopterin on Blood Pressure
- Effect of Valsartan on Carotid Artery Disease
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
- Rationale and Design for Shiga Microalbuminuria Reduction Trial
- Statins in Proteinuric Nephropathies
- Pilot Study of Mycophenolate Mofetil in Congenital Uropathies
- Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs
- Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
- Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
- EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
- Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
- The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects
- Prophylactic Treatment of Episodic Cluster Headache
- Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.
- To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
- Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
- A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Ove
- The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
- Prevention of CHOP-induced Chronic Cardiotoxicity
- Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)
- Efficacy of Pentoxifylline on Chronic Kidney Disease
- Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism
- Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
- Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.
- Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
- Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placeb
- INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
- Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia
- Cognitive/Cerebrovascular Consequences of HTN Treatment
- QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia
- Danish Hypertension Prevention Project - DHYPP
- Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
- Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
- A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes
- Renin Angiotensin System Study (RASS/B-RASS)
- Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
- The Renin-Angiotensin System in Essential Hypertension
- Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study
- Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
- Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
- Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients
- OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
- INVEST: INternational VErapamil SR Trandolapril STudy
- A Morbidity-Mortality and Remodeling Study With Valsartan
- Candesartan in the Prevention of Relapsing Atrial Fibrillation
- Effect of Sulodexide in Overt Diabetic Nephropathy
- Effect of Sulodexide in Early Diabetic Nephropathy
- Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
- Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
- IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
- Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
- Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance
- Scandinavian Candesartan Acute Stroke Trial (SCAST)
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
- Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
- Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network
- Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
- The CLEVER Study - Coreg And Left Ventricular Mass Regression
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
- Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
- Podocyte Retinoids
- Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
- Optimal Treatment for Kidney Disease in HIV Infected Adults
- Angiotensin II Blockade for Chronic Allograft Nephropathy
- HALT Progression of Polycystic Kidney Disease Study B
- Treatment of Diabetic Nephropathy
- Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure
- ACE Inhibition and Novel Cardiovascular Risk Factors
- Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
- Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
- Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
- Genetic Epidemiology of Responses to Antihypertensives
- Prevention of Kidney Transplant Rejection
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Occluded Artery Trial (OAT)
- Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
- Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
- Study of Inherited Changes of Receptors Located on Blood Vessels
- The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
- The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
- Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
- Magnesium in Coronaries (MAGIC)
- Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
- Enalapril After Anthracycline Cardiotoxicity
- Oral Calcium in Pregnant Women With Hypertension
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- Antiarrhythmics Versus Implantable Defibrillators (AVID)
- Treatment of Mild Hypertension Study (TOMHS)
- Studies of Left Ventricular Dysfunction (SOLVD)
Clinical trials list
click for details